Prostate cancer
Results
Phase 3
This trial was looking at giving higher doses of radiotherapy to men with prostate cancer that was contained within the prostate gland (localised).
A method called conformal radiotherapy allows doctors to give a higher dose of radiotherapy. This may be better at controlling cancer, but researchers wanted to find out if having a higher dose of radiotherapy was safe.
All the men who took part in this trial had a few months of hormone therapy before having radiotherapy.
The aims of the trial were to
See if a higher dose of conformal radiotherapy was better at controlling prostate cancer
Learn more about the side effects
Recruitment start: 1 January 1998
Recruitment end: 31 December 2001
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Dearnaley
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer
Last reviewed: 12 July 2012
CRUK internal database number: 687